{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-030779","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2024-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.302083+00:00","generated_at":"2026-06-04T22:08:23.344670+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Outset Medical appoints Brent Lang to board; Director Szyman resigns for Edwards spinoff CEO role","bullets":["Brent D. Lang appointed to the board effective March 12, 2024, filling vacancy left by Catherine Szyman.","Lang is former Chairman & CEO of Vocera Communications, acquired by Stryker for $3 billion in 2022.","Szyman resigned due to pending role as CEO of Edwards Lifesciences' Critical Care spinoff; no disagreement.","Lang will serve on the Audit Committee and be compensated per Outset's non-employee director policy."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-030779","json":"https://secwatch.observer/filing/0000950170-24-030779.json","markdown":"https://secwatch.observer/filing/0000950170-24-030779.md","text":"https://secwatch.observer/filing/0000950170-24-030779.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000095017024030779/0000950170-24-030779-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000095017024030779/om-20240308.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:08:23.344670+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17adb959e7","claim":"Catherine Szyman resigned as Director at Outset Medical, Inc..","evidence_excerpt":"On March 8, 2024, Catherine Szyman, a member of the Board of Directors (the “Board”) of Outset Medical, Inc. (the “Company”), resigned from the Board in preparation for her pending role as Chief Executive Officer of Edwards Lifesciences’ Critical Care spinoff, with such resignation effective March 12, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017024030779/0000950170-24-030779-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"747c709ef4","claim":"Brent D. Lang was appointed as Director at Outset Medical, Inc..","evidence_excerpt":"On March 10, 2024, the Board appointed Brent D. Lang as a new member of the Board and as a member of the Audit Committee of the Board, with such appointment effective March 12, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017024030779/0000950170-24-030779-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}